Next, immunohistochemistry (IHC) was employed to examine BCKDK and p‐RNF8S157 expression in a retrospective cohort of 103 breast cancer patients with well‐characterized clinicopathological features. This evidence concerns the gene BCKDK and breast carcinoma.